HLB Therapeutics Market Cap

HLB Therapeutics has a market cap or net worth of 291.40 billion as of August 14, 2025. Its market cap has decreased by -55.46% in one year.

Market Cap

291.40B

Enterprise Value

320.52B

Revenue

57.22B

Ranking

n/a

PE Ratio

n/a

Stock Price

3,425.00

Market Cap Chart

Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 291.40B, an increase of 175.41%. That is a compound annual growth rate of 6.80%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	291.40B	-68.82%
Dec 30, 2024	934.49B	182.02%
Dec 28, 2023	331.36B	-9.25%
Dec 29, 2022	365.14B	-3.64%
Dec 30, 2021	378.91B	-51.22%
Dec 30, 2020	776.71B	0.46%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	73.45T
Celltrion	38.14T
ALTEOGEN	22.98T
Yuhan	8,383.50B
SK Biopharmaceuticals	7,737.35B
PharmaResearch	7,064.96B
Peptron	6,989.21B
LigaChem Biosciences	5,419.69B

Market Cap Rankings